Total Payments
$313,745
2024 Payments
$40,523
Companies
18
Transactions
541
Medicare Patients
3,032
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$255,411 (81.4%)
Consulting$28,015 (8.9%)
Travel$20,762 (6.6%)
Food & Beverage$9,557 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $252,486 | 115 | 80.5% |
| Consulting Fee | $28,015 | 11 | 8.9% |
| Travel and Lodging | $20,762 | 107 | 6.6% |
| Food and Beverage | $9,557 | 305 | 3.0% |
| Honoraria | $2,925 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $159,163 | 221 | $0 (2022) |
| ABBVIE INC. | $128,466 | 235 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $15,848 | 26 | $0 (2021) |
| Lundbeck LLC | $5,142 | 14 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $4,152 | 5 | $0 (2022) |
| Amgen Inc. | $263.40 | 8 | $0 (2023) |
| Lilly USA, LLC | $146.22 | 7 | $0 (2024) |
| Medtronic Vascular, Inc. | $107.90 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $79.10 | 5 | $0 (2024) |
| ARGENX US, INC. | $71.32 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,523 | 63 | ABBVIE INC. ($40,327) |
| 2023 | $35,002 | 85 | ABBVIE INC. ($34,628) |
| 2022 | $32,090 | 78 | ABBVIE INC. ($24,603) |
| 2021 | $80,243 | 120 | Allergan, Inc. ($33,764) |
| 2020 | $53,262 | 60 | Allergan, Inc. ($53,226) |
| 2019 | $17,312 | 33 | Allergan Inc. ($17,242) |
| 2018 | $24,188 | 51 | Allergan Inc. ($23,896) |
| 2017 | $31,127 | 51 | Allergan Inc. ($31,019) |
All Payment Transactions
541 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $0.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PAIN | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.43 | General |
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $787.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Neuroscience | ||||||
| 08/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/07/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $14.28 | General |
| 07/29/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Neuroscience | ||||||
| 07/24/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Rare Disease | ||||||
| 07/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: PAIN | ||||||
| 05/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | ARGENX US, INC. | — | Food and Beverage | In-kind items and services | $29.09 | General |
| 05/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $17.39 | General |
| 04/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.81 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Travel and Lodging | In-kind items and services | $60.30 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 732 | 66,741 | $1.1M | $402,327 |
| 2022 | 21 | 806 | 65,552 | $1.1M | $405,761 |
| 2021 | 18 | 757 | 61,202 | $1.0M | $385,158 |
| 2020 | 21 | 737 | 64,537 | $1.0M | $392,415 |
Total Patients
3,032
Total Services
258,032
Medicare Billing
$1.6M
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 85 | 65,801 | $654,720 | $312,930 | 47.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $32,640 | $12,220 | 37.4% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 34 | 92 | $54,250 | $11,566 | 21.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 80 | 86 | $89,010 | $11,027 | 12.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 45 | 45 | $76,060 | $9,450 | 12.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 82 | 117 | $34,245 | $8,379 | 24.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 55 | 145 | $32,465 | $8,310 | 25.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 24 | 75 | $31,875 | $7,753 | 24.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 90 | 120 | $22,800 | $5,715 | 25.1% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 12 | 34 | $15,300 | $4,033 | 26.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 32 | 32 | $24,960 | $3,179 | 12.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $7,770 | $2,985 | 38.4% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 17 | 17 | $36,788 | $2,618 | 7.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 21 | $3,066 | $1,448 | 47.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 16 | 17 | $2,346 | $713.49 | 30.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 83 | 64,500 | $632,840 | $305,399 | 48.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 102 | 156 | $45,854 | $12,265 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $27,520 | $10,396 | 37.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 26 | 78 | $44,520 | $9,612 | 21.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 51 | 147 | $33,075 | $8,896 | 26.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 31 | 31 | $52,855 | $7,157 | 13.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 62 | 64 | $49,276 | $6,669 | 13.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 47 | 48 | $49,680 | $6,496 | 13.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 26 | 61 | $25,925 | $6,308 | 24.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 31 | 31 | $45,570 | $6,146 | 13.5% |
About Dr. Jon Grudem, MD
Dr. Jon Grudem, MD is a Neurology healthcare provider based in North Sioux City, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477649531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Grudem, MD has received a total of $313,745 in payments from pharmaceutical and medical device companies, with $40,523 received in 2024. These payments were reported across 541 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($252,486).
As a Medicare-enrolled provider, Grudem has provided services to 3,032 Medicare beneficiaries, totaling 258,032 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location North Sioux City, SD
- Active Since 10/05/2006
- Last Updated 01/13/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1477649531
Products in Payments
- BOTOX (Biological) $142,928
- UBRELVY (Drug) $94,883
- QULIPTA (Drug) $25,499
- NURTEC ODT (Drug) $20,042
- BOTOX (Drug) $17,219
- VYEPTI (Biological) $5,116
- BOTOX CHRONIC MIGRAINE (Drug) $3,570
- BOTOX NEURO REHAB (Drug) $3,341
- Aimovig (Biological) $185.73
- EMGALITY (Drug) $130.17
- Reveal LINQ (Device) $107.90
- Duopa (Drug) $90.08
- BOTOX COSMETIC (Biological) $57.68
- Trudhesa (Drug) $48.92
- Austedo XR (Drug) $42.22
- RYTARY (Drug) $41.05
- AJOVY (Biological) $36.88
- ULTOMIRIS (Biological) $33.39
- REXULTI (Drug) $25.75
- NUPLAZID (Drug) $23.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.